vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与TRUSTCO BANK CORP N Y（TRST）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是TRUSTCO BANK CORP N Y的1.5倍（$75.5M vs $49.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
TRUSTCO BANK CORP N Y是一家美国区域性金融控股企业，提供零售及商业银行全品类产品服务，涵盖个人存贷、住房抵押贷款、小微企业融资、财富管理等业务，主要服务纽约、佛罗里达等多个美国州的个人及小微企业客户。
PBYI vs TRST — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$49.5M
两年增速更快
PBYI
近两年复合增速
6.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $49.5M |
| 净利润 | — | $16.3M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 32.9% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | 14.1% |
| 每股收益（稀释后） | $0.26 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITRST
| Q1 26 | — | $49.5M | ||
| Q4 25 | $75.5M | $48.2M | ||
| Q3 25 | $54.5M | $47.8M | ||
| Q2 25 | $52.4M | $46.6M | ||
| Q1 25 | $46.0M | $45.3M | ||
| Q4 24 | $59.1M | $43.3M | ||
| Q3 24 | $80.5M | $43.6M | ||
| Q2 24 | $47.1M | $43.4M |
净利润PBYITRST
| Q1 26 | — | $16.3M | ||
| Q4 25 | — | $15.6M | ||
| Q3 25 | $8.8M | $16.3M | ||
| Q2 25 | $5.9M | $15.0M | ||
| Q1 25 | $3.0M | $14.3M | ||
| Q4 24 | — | $11.3M | ||
| Q3 24 | $20.3M | $12.9M | ||
| Q2 24 | $-4.5M | $12.6M |
毛利率PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 43.7% | ||
| Q3 25 | 17.6% | 44.6% | ||
| Q2 25 | 12.7% | 42.3% | ||
| Q1 25 | 8.7% | 41.3% | ||
| Q4 24 | 22.6% | 34.0% | ||
| Q3 24 | 27.4% | 38.8% | ||
| Q2 24 | -4.6% | 37.9% |
净利率PBYITRST
| Q1 26 | — | 32.9% | ||
| Q4 25 | — | 32.3% | ||
| Q3 25 | 16.2% | 34.0% | ||
| Q2 25 | 11.2% | 32.3% | ||
| Q1 25 | 6.5% | 31.5% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | 25.2% | 29.5% | ||
| Q2 24 | -9.6% | 28.9% |
每股收益（稀释后）PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | $0.26 | $0.85 | ||
| Q3 25 | $0.17 | $0.86 | ||
| Q2 25 | $0.12 | $0.79 | ||
| Q1 25 | $0.06 | $0.75 | ||
| Q4 24 | $0.40 | $0.59 | ||
| Q3 24 | $0.41 | $0.68 | ||
| Q2 24 | $-0.09 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $112.9M |
| 股东权益账面价值 | $130.3M | $670.9M |
| 总资产 | $216.3M | $6.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $730.4M | ||
| Q3 25 | $94.4M | $695.6M | ||
| Q2 25 | $96.0M | $713.6M | ||
| Q1 25 | $93.2M | $756.1M | ||
| Q4 24 | $101.0M | $641.8M | ||
| Q3 24 | $96.7M | $523.0M | ||
| Q2 24 | $96.8M | $536.1M |
总债务PBYITRST
| Q1 26 | — | $112.9M | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYITRST
| Q1 26 | — | $670.9M | ||
| Q4 25 | $130.3M | $686.6M | ||
| Q3 25 | $115.3M | $692.0M | ||
| Q2 25 | $104.7M | $692.8M | ||
| Q1 25 | $97.1M | $687.8M | ||
| Q4 24 | $92.1M | $676.3M | ||
| Q3 24 | $71.1M | $669.0M | ||
| Q2 24 | $48.5M | $655.2M |
总资产PBYITRST
| Q1 26 | — | $6.5B | ||
| Q4 25 | $216.3M | $6.4B | ||
| Q3 25 | $202.9M | $6.3B | ||
| Q2 25 | $194.9M | $6.3B | ||
| Q1 25 | $196.2M | $6.3B | ||
| Q4 24 | $213.3M | $6.2B | ||
| Q3 24 | $220.7M | $6.1B | ||
| Q2 24 | $205.0M | $6.1B |
负债/权益比PBYITRST
| Q1 26 | — | 0.17× | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $57.6M | ||
| Q3 25 | $9.7M | $12.8M | ||
| Q2 25 | $14.1M | $27.1M | ||
| Q1 25 | $3.6M | $1.3M | ||
| Q4 24 | $15.6M | $59.4M | ||
| Q3 24 | $11.0M | $16.5M | ||
| Q2 24 | $1.0M | $18.7M |
自由现金流PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $45.7M | ||
| Q3 25 | $9.7M | $10.0M | ||
| Q2 25 | $14.1M | $24.9M | ||
| Q1 25 | $3.6M | $-3.3M | ||
| Q4 24 | $15.6M | $54.6M | ||
| Q3 24 | $11.0M | $15.6M | ||
| Q2 24 | $1.0M | $17.6M |
自由现金流率PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 95.0% | ||
| Q3 25 | 17.7% | 20.9% | ||
| Q2 25 | 26.8% | 53.5% | ||
| Q1 25 | 7.7% | -7.2% | ||
| Q4 24 | 26.4% | 126.0% | ||
| Q3 24 | 13.7% | 35.7% | ||
| Q2 24 | 2.1% | 40.5% |
资本支出强度PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 24.6% | ||
| Q3 25 | 0.0% | 5.9% | ||
| Q2 25 | 0.0% | 4.5% | ||
| Q1 25 | 0.1% | 10.0% | ||
| Q4 24 | 0.0% | 11.3% | ||
| Q3 24 | 0.0% | 2.1% | ||
| Q2 24 | 0.0% | 2.6% |
现金转化率PBYITRST
| Q1 26 | — | — | ||
| Q4 25 | — | 3.70× | ||
| Q3 25 | 1.10× | 0.79× | ||
| Q2 25 | 2.41× | 1.80× | ||
| Q1 25 | 1.21× | 0.09× | ||
| Q4 24 | — | 5.27× | ||
| Q3 24 | 0.54× | 1.28× | ||
| Q2 24 | — | 1.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TRST
| Net Interest Income | $44.7M | 90% |
| Noninterest Income | $4.8M | 10% |
